KR20040108476A - Making methods of effectively bio-transformed ginsengs using the cultivation of edible and medicinal mushrooms - Google Patents

Making methods of effectively bio-transformed ginsengs using the cultivation of edible and medicinal mushrooms Download PDF

Info

Publication number
KR20040108476A
KR20040108476A KR1020030039079A KR20030039079A KR20040108476A KR 20040108476 A KR20040108476 A KR 20040108476A KR 1020030039079 A KR1020030039079 A KR 1020030039079A KR 20030039079 A KR20030039079 A KR 20030039079A KR 20040108476 A KR20040108476 A KR 20040108476A
Authority
KR
South Korea
Prior art keywords
ginseng
cordyceps
cordyceps sinensis
effect
kctc
Prior art date
Application number
KR1020030039079A
Other languages
Korean (ko)
Inventor
한영환
이태희
김성준
김장한
Original Assignee
한영환
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한영환 filed Critical 한영환
Priority to KR1020030039079A priority Critical patent/KR20040108476A/en
Publication of KR20040108476A publication Critical patent/KR20040108476A/en

Links

Classifications

    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09FDISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
    • G09F9/00Indicating arrangements for variable information in which the information is built-up on a support by selection or combination of individual elements
    • G09F9/30Indicating arrangements for variable information in which the information is built-up on a support by selection or combination of individual elements in which the desired character or characters are formed by combining individual elements
    • G09F9/35Indicating arrangements for variable information in which the information is built-up on a support by selection or combination of individual elements in which the desired character or characters are formed by combining individual elements being liquid crystals
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Theoretical Computer Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE: A method of making a ginseng product by soaking cut pieces of ginseng in the yeast extract, inoculating them with mushroom strains such as Paecilomyces tenuipes, Cordyceps militaris, Cordyceps sinensis and Phellinus Linteus and then culturing them is provided. The product has the increased content of ginsenoside and beta-glucan as well as has enhanced antioxidant effect, antineoplastic effect, antifatigue effect and skin whitening effect. CONSTITUTION: Ginseng is cut into a predetermined size, soaked in 0.1 to 10% of the yeast extract for 2 to 24hr and sterilized at 121deg.C at 1.5atm for 15 to 60min. Mushroom strains such as Paecilomyces tenuipes(KCTC 18063P), Cordyceps militaris(KCTC 6064), Cordyceps sinensis(KCTC 16137) and Phellinus Linteus(KCTC 10055BP) are inoculated into the culture medium and then cultured at 15 to 35deg.C at 100 to 1,000lux for 1 to 4 weeks.

Description

식용 및 약용버섯 배양을 이용한 기능성 생변환 인삼의 제조법{Making methods of effectively bio-transformed ginsengs using the cultivation of edible and medicinal mushrooms}Making methods of effectively bio-transformed ginsengs using the cultivation of edible and medicinal mushrooms

본 발명은 식용 및 약용버섯 배양을 통한 인삼의 생변환법을 이용하여 고기능성, 고부가가치의 독창적인 인삼제품을 제조하는 방법에 관한 것이다.The present invention relates to a method for producing a high functional, high value-added original ginseng product using the biotransformation method of ginseng through edible and medicinal mushroom culture.

기존의 가공인삼의 형태는 고려인삼의 원형을 유지하면서 건조를 기본적인 수단으로 하여 가공하는 1차 가공인삼(백삼 및 홍삼)과 수삼 또는 1차 가공삼을 원료로 하여 다시 다양한 목적에 따라 여러 가지 형태로 가공하는 2차 가공제품으로 구분할 수 있다. 그러나 2차 가공제품 역시 1차 가공인삼을 원료로 하기 때문에 결국 백삼과 홍삼이라는 2가지 형태의 기본적인 원료로부터 출발하게 된다. 이러한 기본적인 원료는 그 가공법이 단순히 열처리에 의한 것이다.Conventional processed ginseng is made from primary processed ginseng (white and red ginseng) and fresh ginseng or primary processed ginseng which are processed by drying as a basic means while maintaining the original shape of Korean ginseng. It can be divided into secondary processed products processed by. However, since the second processed product also uses the first processed ginseng, it starts with two types of basic raw materials: white ginseng and red ginseng. The basic raw material is that the processing method is simply heat treatment.

이와 같이 인삼의 재배 및 단순가공, 홍삼의 기능성 및 제형화에 한정되어온 연구 등은 홍삼을 세계최고의 브랜드로 만들었던 마케팅 요소가 백삼의 수출을 악화시키는 원인이 되어왔을 뿐 아니라 가공방법을 단순화 할 수밖에 없게 하여 세계적 수준의 다양한 고려인삼의 제품 등을 만드는데 걸림돌이 되어온 것이 사실이다. 최근 새로운 고려인삼의 가공품들이 출시되었으나 이러한 기술역시 기존의 열처리 및 효소를 이용한 가공법의 변형일 뿐 두 가지 이상의 원료가 갖는 장점을 상승적으로 작용하는 신기능적 패러다임의 변화에는 이르지 못하였다.The research that has been limited to the cultivation and simple processing of ginseng, and the function and formulation of red ginseng has not only caused the export factor of white ginseng to deteriorate the export of white ginseng but also simplifies the processing method. It is true that it has been an obstacle to making world-class variety of Korean ginseng products. Recently, new processed products of Korean ginseng have been released, but these technologies have not been able to change the new functional paradigm that is synergistic with the advantages of two or more raw materials.

본 발명과 관련하여 미생물을 이용한 인삼의 연구에는 국내 논문 김상달(김상달. 1989.Rhizopus japonicus에 의한 ginsenoside Rb1 전환효소의 생산조건. 한국균학회지. 17(1):31-34) 및 김상달 외 1인(김상달, 서정훈. 1982.Rhizopussp. 가 생산하는 효소에 의한 인삼 saponin의 전환.Kor. J. Appl. Microbiol. Bioeng. 10(4)267-273)가 있으나 이는Rhizopus라는 진균류를 이용하여 진세노사이드 중 Rb1의 전환효소에 관한 연구로 본 발명에서 사용하고자 하는 미생물(Paecilomyces tenuipes, Cordyceps militaris, Cordyceps sinensis, Phellinus linteus)과는 전혀 다른 균주이며 또한 생변환 인삼의 생리활성에 관한 연구결과는 전혀 찾아볼 수 가 없다.In the study of ginseng using microorganisms in relation to the present invention, Korean paper Kim, Sang-Dal (Kim, Sang-Dal. 1989. Production conditions of ginsenoside Rb1 converting enzyme by Rhizopus japonicus . Journal of the Korean Society of Bacteria. 17 (1): 31-34) (Kim Sang-dal, Seo Jung-hoon. 1982. Conversion of ginseng saponin by enzymes produced by Rhizopus sp. Kor. J. Appl. Microbiol. Bioeng . 10 (4) 267-273), but this is done by using a fungus called Rhizopus . It is a study on the conversion enzyme of Rb1 in the side and it is a strain that is completely different from the microorganisms ( Paecilomyces tenuipes, Cordyceps militaris, Cordyceps sinensis, Phellinus linteus ) to be used in the present invention. Can't see

미생물의 인삼배지 배양과 관련된 기술은 국내 특허등록번호 0178863의 인삼사포닌 대사 생산물의 제조법이 있으나, 본 발명과는 사용하는 균주가 다르며 또한 미생물에 의해 생산되는 대사물 또한 다르므로 동충하초 및 상황버섯을 이용하는 본 발명과는 전혀 다르다.The technology related to the culture of ginseng medium of microorganisms has a manufacturing method of ginseng saponin metabolite of Korean Patent Registration No. 0178863, but because the strains used are different from the present invention and the metabolites produced by microorganisms are also different, cordyceps and situation mushrooms are used. It is completely different from the present invention.

종래의 인산가공기술은 단순히 열처리법에 의한 것이다. 기존의 홍삼제조법역시 수삼을 '증삼(삼을 증기로 찌는 것)과 식힘'을 9차례 반복하는 번거로운 열처리 방법을 통해 제작 되는데 이렇게 9차례나 되는 열처리 과정을 거치므로 매우 번거롭고 비용이 많이 소요되는 문제점이 발생한다. 또한 가공방법을 열처리에 의존하는 단순한 방법을 이용하므로 다양한 세계적 수준의 고려인삼의 제품을 만드는데 걸림돌이 되어온 것이 사실이다. 그러므로, 인삼의 가공방식 다양화 및 기능성 연구를 통하여 고기능성, 고부가가치 제품을 생산하여야 한다. 즉, 순품수준의 성분을 이용해 특정 생리활성 효능을 기대하고 설계한 제품 개발이 이뤄져야 하며, 이를 위하여 생변환 방법을 활용한 고려인삼의 가공법의 개발이 필요하다.Conventional phosphoric acid processing technology is simply a heat treatment method. Existing red ginseng manufacturing method is produced through cumbersome heat treatment method that repeats 'Ginseng (steaming ginseng with steam) and cooling' nine times, and it is very troublesome and expensive because it goes through 9 times of heat treatment process. This happens. In addition, the processing method is a simple method that relies on heat treatment, so it has been an obstacle to the production of various world-class Korean ginseng products. Therefore, high functional and high value-added products should be produced by diversifying the processing method and researching functionalities of ginseng. In other words, it is necessary to develop a product designed in anticipation of specific physiological activity using pure ingredients, and for this, development of Korean ginseng processing method using bioconversion method is necessary.

본 발명을 통하여 생산된 생변환 인삼은 진세노사이드 및 베타글루칸 등 각각의 독특한 생리활성물질이 단독 및 배가된 효능이 나타난다. 따라서 본 발명의 목표는 식용 및 약용 버섯 배양을 통한 인삼의 생변환법을 이용하여 고기능성, 고부가가치의 독창적인 인삼제품을 만드는데 있다.Bio-converted ginseng produced through the present invention exhibits the efficacy of single and doubled unique bioactive substances such as ginsenosides and betaglucans. Therefore, an object of the present invention is to create a high functional, high value-added original ginseng product by using the biotransformation method of ginseng through edible and medicinal mushroom culture.

도 1은 눈꽃동충하초가 배양된 인삼의 전면도1 is a front view of ginseng cultured Snow Cordyceps sinensis

도 2는 생변환 인삼의 진세노사이드 분석의 TLC 전개도Figure 2 TLC development diagram of ginsenoside analysis of biotransformation ginseng

Control : 아래로부터 위로 Rb, Rd, Re 및 RgControl: Rb, Rd, Re and Rg from bottom up

G : 인삼G: Ginseng

PT-G : 눈꽃동충하초 생변환 인삼PT-G: Snow Transformed Ginseng

CS-G : 시넨시스동충하초 생변환 인삼CS-G: Synensis Cordyceps Sinensis Ginseng

본 발명에 사용된 균주는 눈꽃동충하초(Paecilomyces tenuipesKCTC 18063P), 번데기동충하초(Cordyceps militarisKCTC 6064), 시넨시스 동충하초(Cordyceps sinensisKCTC 26137) 및 상황버섯(Pellinus linteusKCTC 10055BP)을 계대 배양하여 사용하였으며, 인삼은 농협중앙회에서 판매하는 1등급 건삼을 사용하였다.The strain used in the present invention was used by subcultured with Paecilomyces tenuipes KCTC 18063P, chrysalis Cordyceps sinensis ( Cordyceps militaris KCTC 6064), Synyces cordyceps sinensis KCTC 26137 and Pellinus linteus KCTC 10055BP. Ginseng used Grade 1 dry ginseng sold by the National Agricultural Cooperative Federation.

다음의 실시예로 본 발명을 보다 구체적으로 설명한다. 이 실시예는 본 발명의 예시를 나타내는 것으로서 본 발명의 기술적 범위를 제한하는 것은 아니다.The present invention is explained in more detail with reference to the following examples. This embodiment shows an example of the present invention and does not limit the technical scope of the present invention.

실시예 1Example 1

동충하초 및 상황버섯 배양법을 이용한 생변환 인삼의 제조Preparation of Biotransformed Ginseng Using Cordyceps Sinensis and Sacred Mushroom Culture

건삼 원료를 적절한 크기로 절단하고 효모추출물 및 쏘이톤과 같은 미생물 배양용 첨가물 용액(0.1-10%)을 제조한다. 2-24시간 동안 첨가물 용액을 고려인삼에 충분히 흡수시킨 후 멸균한다. 멸균하여 준비된 고려인삼에 기 배양하여 준비해놓은 눈꽃동충하초, 번데기동충하초, 시넨시스동충하초 및 상황버섯 균주를 각각 접종(0.1-20%)한다. 접종된 고려인삼을 적정 온도(15-35도)에서 약 1주일간 배양하여 균사체를 생육시킨다. 설정된 환경(적정 온도에서 5도 낮은 온도 및 100-1,000 lux의 광조사)에서 약 1-2주간 추가 배양한 다음 균주에 따른 생리적 특성의 발현을 확인한다(눈꽃동충하초의 경우 노란색의 자실체 발생, 번데기동충하초의 경우 오렌지색의 색소생성 및 자실체의 생성, 상황버섯의 경우 진노란색의 색소생성을 확인한다). 50-105도의 온도에서 열풍 건조하여 동충하초 및 상황버섯 생변환 인삼을 제조하였다.The dried ginseng raw material is cut into appropriate sizes, and a solution for adding a microbial culture such as yeast extract and soyton (0.1-10%) is prepared. The additive solution is sufficiently absorbed into Korean ginseng for 2-24 hours and then sterilized. Inoculate (0.1-20%) strains of Snow Cordyceps, Pupa Cordyceps, Sinensis cordyceps, and S. mushroom strains prepared by cultivating Korean ginseng prepared by sterilization. Inoculated Korean ginseng is incubated for about 1 week at an appropriate temperature (15-35 degrees) to grow mycelia. After further incubation for 1-2 weeks in the set environment (light at a low temperature of 5 degrees and 100-1,000 lux), the expression of physiological characteristics according to the strains is confirmed. In the case of Cordyceps sinensis, the orange pigmentation and the fruiting body are produced, and in the case of the situation mushroom, the yellowish pigment production is confirmed). Hot-air dried at a temperature of 50-105 degrees to produce Cordyceps sinensis and S. mushroom ginseng.

눈꽃동충하초 생변환 인삼의 예를 도 1에 나타내었다.1 shows an example of a live ginseng Cordyceps sinensis ginseng.

실시예 2Example 2

생변환 인삼의 열수 및 용매추출물의 제조Preparation of Hydrothermal and Solvent Extracts of Raw Ginseng

식의약품 기능성 소재 및 약리효능 검정실험을 위하여 각각의 생변환 인삼으로부터 열수 및 용매추출물을 제조하였다. 열수추출물의 경우에는 각각의 생변환 인삼을 가열 순환식 추출기에 넣고 무게의 3배에(v/w) 해당되는 물을 가한다음 약 100도에서 2-6시간 동안 3회 추출하여 여과하고 동결건조하여 최종 추출물을 얻었다. 용매추출물의 경우 각각의 생변환 인삼을 가열순환식 추출탱크에 넣고 50-70% 에탄올 또는 메탄올을 무게의 3배(v/w)되게 가하여 75-85℃에서 2-6시간동안 3회 추출한 후 여과, 감압농축 및 동결건조하여 최종 추출물을 얻었다.Hot water and solvent extracts were prepared from each of the bio-converted ginseng for the functional food and pharmacological efficacy assay. In the case of hot water extracts, each of the raw conversion ginseng is placed in a heating circulation extractor, added to water three times the weight (v / w), extracted three times at about 100 degrees for 2-6 hours, filtered, and lyophilized. The final extract was obtained. In the case of the solvent extract, each of the live-converted ginseng was put in a heating circulation extraction tank, and 50-70% ethanol or methanol was added three times the weight (v / w) and extracted three times at 75-85 ° C. for 2-6 hours. Filtration, concentration under reduced pressure, and lyophilization gave a final extract.

실시예 3Example 3

TLC를 이용한 생변환 인삼의 진세노사이드의 분석Analysis of Ginsenosides of Biotransformed Ginseng by TLC

생변환 인삼의 용매추출법에 의해 추출된 추출물을 극성정도에 따른 유기용매 분획을 통하여 분획한 후 각각의 분획물의 표준품 TLC 분석법을 이용하여 각각의 독특한 성분을 표준품과 비교 및 확인하였다. 전개용매 및 분석 방법은 논문의 방법(곽이성, 김미주, 김은희, 김영애. 1997. 인삼사포닌 혼합물의 신속한 추출.Kor. J. Food. Sci. Techol.29(6)1327-1329)을 이용하였으며, 그 결과를 도 2로 나타내었다.Extracts extracted by solvent extraction of fresh ginseng were fractionated through organic solvent fractions according to the polarity, and then each unique component was compared and confirmed by standard TLC analysis of each fraction. The developing solvent and analysis method were used in the method of the paper (Kwak, Sung-Sung, Mi-Ju Kim, Eun-Hee Kim, Young-Ae Kim, 1997. Rapid extraction of ginseng saponin mixture.Kor. J. Food.Sci. The result is shown in FIG.

눈꽃동충하초 생변환 인삼과 시넨시스동충하초 생변환 인삼의 경우 G-Re 위쪽 부분의 새로운 갈색 spot이 확인되었으며 특히 시넨시스 동충하초 생변환 인삼의 경우 G-Rd 로 추정되는 진세노사이드의 생성이 증폭되었다.Newly formed brown spots in the upper part of G-Re have been identified in the Ginseng Cordyceps and Ginseng mutant ginseng, and Ginsenosides, which are assumed to be G-Rd, have been amplified.

실시예 4Example 4

에탄올 침전법을 이용한 생변환 인삼의 면역활성 베타글루칸 분석Analysis of Immune Activity Beta-glucans of Biotransformed Ginseng by Ethanol Precipitation

동충하초, 상황버섯 및 인삼의 대표적 면역증강 다당류인 베타글루칸의 함량을 측정하기 위하여 에탄올 침전법을 이용하였다. 자세한 분석 방법은 논문의 방법(Sim, J.S., H.R. Chang, E.G. Min, Y.H. Kim and Y.H. Han. 2001. Cytotoxicity ofPaecilomyces tenuipesagainst human carcinoma cells, HepG2 and MCF-7in vitro. Mycobiol. 29(3)170-172)을 사용하였으며, 그 결과를 표 1에 나타내었다.Ethanol precipitation was used to determine the content of beta glucan, a representative immune-enhancing polysaccharide of Cordyceps sinensis, S. mushroom and Ginseng. For detailed analytical methods, see the method of the paper (Sim, JS, HR Chang, EG Min, YH Kim and YH Han. 2001. Cytotoxicity of Paecilomyces tenuipes against human carcinoma cells, HepG2 and MCF-7 in vitro.Mycobiol . 29 (3) 170 -172) was used, and the results are shown in Table 1.

눈꽃동충하초 생변환 인삼의 경우 대조군인 건삼에 비해 대표적 면역증강 다당류인 베타글루칸의 함량이 약 44% 높았다.In the case of snow ginseng and herbaceous live ginseng, the content of beta glucan, a representative immune-enhancing polysaccharide, was about 44% higher than that of the control ginseng.

표 1Table 1

건삼과 눈꽃동충하초 생변환 인삼의 베타글루칸 함량Beta-Glucan Contents of Raw Ginseng and Ginseng Cordyceps Sinensis

샘플Sample 베타글루칸 함유량(%)Beta Glucan Content (%) 대조군(건삼)Control group (Ginseng) 13.213.2 눈꽃동충하초 생변환 인삼Snow Cordyceps Sinensis Transforming Ginseng 19.019.0

실시예 5Example 5

리보플라빈 산화법을 이용한 생변환 인삼의 항산화 측정Antioxidant Measurement of Biotransformed Ginseng Using Riboflavin Oxidation

생변환 인삼의 항산화력을 측정하기 위하여 광에 의해 리보플라빈 산화시 발생하는 자유라디칼 제거효과를 측정하는 논문의 방법을 사용하였으며, 그 결과를 표 2에 나타내었다(Winterborn, C.C., R.E. Hawkins, M. Brian, and R.W. Carrell. 1975. The estimation of red cell superoxide dismutase activity.J. Lab. Clin. Med. 85:337).In order to measure the antioxidant power of biotransformed ginseng, we used the method of the paper to measure the free radical scavenging effect generated by the oxidation of riboflavin by light. The results are shown in Table 2 (Winterborn, CC, RE Hawkins, M. Brian, and RW Carrell. 1975. The estimation of red cell superoxide dismutase activity.J. Lab. Clin. Med . 85: 337.

눈꽃동충하초 생변환 인삼의 경우 1% 열수 추출물의 리보플라빈 항산화 효과를 비교하였을때 대조군인 일반 건삼 및 홍삼에 비해 항산화력이 각각 14% 및 60% 증가하였다..When comparing the antioxidant effects of 1% hydrothermal extracts with riboflavin, the antioxidant powers of 14% and 60% increased, respectively, compared to those of the control group Dried Ginseng and Red Ginseng.

표 2TABLE 2

리보플라빈 산화법을 이용한 생변환 인삼의 항산화 효과의 측정Determination of Antioxidant Effect of Biotransformed Ginseng Using Riboflavin Oxidation

샘플(1% 열수 추출물)Sample (1% hydrothermal extract) 항산화 효과(%)Antioxidative effect(%) 대조군(건삼)Control group (Ginseng) 85.185.1 대조군(홍삼)Control group (red ginseng) 60.260.2 눈꽃동충하초 생변환 인삼Snow Cordyceps Sinensis Live Ginseng 96.796.7

실시예 6Example 6

MTT법을 이용한 생변환 인삼의 항종양 효과Antitumor Effect of Fresh Ginseng Using MTT Method

생변환 인삼의 항종양 효과를 측정하기 위하여 암세포와 반응하는 MTT-formazan의 농도를 측정하는 MTT법을 논문상의 방법을 이용하여 측정하였으며 그 결과는 표 3에 나타내었다(Sim, J.S., H.R. Chang, E.G. Min, Y.H. Kim and Y.H. Han. 2001. Cytotoxicity ofPaecilomyces tenuipesagainst human carcinoma cells, HepG2 and MCF-7in vitro. Mycobiol. 29(3)170-172.)In order to measure the anti-tumor effect of biotransformed ginseng, the MTT method, which measures the concentration of MTT-formazan reacting with cancer cells, was measured using the method of the paper. The results are shown in Table 3 (Sim, JS, HR Chang, EG Min, YH Kim and YH Han. 2001. Cytotoxicity of Paecilomyces tenuipes against human carcinoma cells, HepG2 and MCF-7 in vitro.Mycobiol . 29 (3) 170-172.)

눈꽃동충하초 생변환 인삼의 경우 대조군으로 사용된 인삼 및 홍산과 비교시 HeLa 암세포주에 대한 항 종양활성이 상대적으로 우수하였다.Compared to ginseng and red acid used as control, ginseng Cordyceps sinensis-transformed ginseng showed superior antitumor activity against HeLa cancer cell line.

표3Table 3

MTT법을 이용한 생변환 인삼의 항종양효과Antitumor Effect of Fresh Ginseng Using MTT Method

샘플(열수 추출물 25 mg/ml)Sample (hot water extract 25 mg / ml) 종양세포의 생존율(HeLa cell, %)Tumor cell survival rate (HeLa cell,%) 대조군(건삼)Control group (Ginseng) 75.975.9 대조군(홍삼)Control group (red ginseng) 79.479.4 눈꽃동충하초 생변환 인삼Snow Cordyceps Sinensis Transforming Ginseng 60.060.0

실시예 7Example 7

생변환 인삼의 항피로효과Anti-fatigue Effect of Raw Ginseng

생변환 인삼의 항피로효과는 수조에 ICR게 8주령 마우스를 이용하여 강제수영시험법(심진영외 6인. 2000. 눈꽃동충하초의 약물활성.Kor. J. Pharmacogn. 31(2):163-167.)을 사용하였으며, 그 결과는 표 4에 나타내었다.Anti-fatigue effect of freshly transformed ginseng was examined by forced swimming test using ICR crab 8-week-old mice in the tank (Sim Jin Young et al., 2000. Drug Activity of Snow Cordyceps. Kor. J. Pharmacogn . .) Was used, and the results are shown in Table 4.

눈꽃동충하초 생변환 인삼의 경우 대조군으로 사용된 눈꽃동충하초 단독 처리군과 비교시 약 60-70% 이상의 항피로효과를 관찰할 수 있었으며, 무처리 대조군과 비교시 2.6배 높은 수영능력 결과가 나타났다.In the case of the lively transformed ginseng of the Cordyceps sinensis, anti-fatigue effect of more than about 60-70% was observed when compared with the control group of the Snow Cordyceps sinensis alone, which was 2.6 times higher than the control group.

표4Table 4

마우스 수영능력평가를 이용한 생변환 인삼의 항피로 효과Anti-fatigue effect of freshly transformed ginseng using mouse swimming ability evaluation

샘플Sample 대조군에 대한 상대적 수영시간(%)% Swimming time relative to control 대조군(무 투여)Control group (no administration) 100100 건삼 투여군Dried ginseng administration group 128128 홍삼 투여군Red ginseng group 146146 눈꽃동충하초 생변환 인삼 투여군Snowmobile Cordyceps Biotransformation Ginseng Administration Group 259259

실시예 8Example 8

생변환 인삼의 미백효과Whitening Effect of Raw Ginseng

생변환 인삼의 미백효과를 측정하기 위하여 멜라닌 색소생성에 관여하는 효소인 티로시나아제의 활성을 억제하여 미백효과를 측정하였며 그 결과를 표5에 나타내었다.(심미희. 2001. 산삼의 배양 및 그 응용에 관한 연구. 대한화장품학회. 27(2)45-56.)In order to measure the whitening effect of fresh ginseng, the whitening effect was measured by inhibiting the activity of tyrosinase, an enzyme involved in melanin pigment production, and the results are shown in Table 5. (Sim, Mi-hee. 2001. Culture and production of wild ginseng A study on its application, Korean Society of Cosmetic Products, 27 (2) 45-56.)

실험결과 시넨시스동충하초 생변환 인삼의 경우 인삼 및 홍삼군과 비교시 우수한 티로시나아제 활성 억제 효과를 보여주었다.Experimental results showed that synensis Cordyceps sinensis ginseng showed a superior inhibitory effect on tyrosinase activity compared to ginseng and red ginseng.

표 5Table 5

DOPA를 기질로 한 생변환 인삼의 티로시나아제 활성억제 효과Inhibition of Tyrosinase Activity of Bio-Converted Ginseng Based on DOPA

샘플Sample 항 티로시나아제 효과(%)Anti tyrosinase effect (%) 건삼 투여군Dried ginseng administration group 64.864.8 홍삼 투여군Red ginseng group 51.851.8 시넨시스동충하초 생변환 인삼 투여군Sinensis Cordyceps Sinensis Ginseng Administration Group 82.382.3

실시예 9Example 9

음료의 제조Manufacture of beverages

눈꽃동충하초, 번데기동충하초, 시넨시스동충하초 및 상황버섯 생변환 인삼 추출물을 각각 0.01-0.5% (w/v) 넣고, 대추추출물 15%, 당귀추출물 7% 및 액상과당 7.4%를 혼합한 후 정제수를 첨가 혼합하고 드링크용 병 또는 파우치에 충전하여 살균 후 실온으로 냉각하여 음료를 제조하였다.Add 0.01-0.5% (w / v) of Snowmobile Cordyceps Sinensis, Pupa Cordyceps Sinensis, Sinensis Cordyceps Sinensis, and Green Mushroom Ginseng Extract, respectively, mix 15% Jujube Extract, 7% Angelica Extract and 7.4% Liquid Fructose, and add purified water. After mixing, filling into a drink bottle or pouch, sterilization and cooling to room temperature to prepare a beverage.

실시예 10Example 10

생약제제의 제조Preparation of Herbal Medicines

눈꽃동충하초, 번데기동충하초, 시넨시스동충하초 및 상황버섯 생변환 인삼 추출물 각각 0.01-30% 에 영양보조성분 (비타민, 초산에스테르, 니코틴산아미드 등), 올리고당, 50% 주정을 조성분의 5-10% 되도록 첨가하여 혼합하였다. 상기 혼합물에 멸균정제수 10%를 첨가 혼합하고 직경 1-2 mm의 과립상으로 성형하였다. 상기 성형된 과립을 건조시킨 후 12-14 메쉬를 통과시켜 균일하게 과립을 제조하였다. 상기 제조된 과립은 적당량씩 압출성형되어 정제 또는 분말로 되거나, 경질캡슐에 충전되어 경질캡슐로 제조될 수 있다.Add 0.01 to 30% of supplementary ginseng extracts from Snowflower Cordyceps, Pupa Cordyceps Sinensis, Sinensis Cordyceps Sinensis and Situary Mushrooms to supplement nutritional supplements (Vitamin, Acetate, Niacinamide, etc.), oligosaccharides, and 50% alcohol to 5-10% of the composition. And mixed. 10% of sterile purified water was added to the mixture and mixed to form granules having a diameter of 1-2 mm. The molded granules were dried and then passed through a 12-14 mesh to uniformly prepare granules. The granules prepared above may be extruded by appropriate amounts into tablets or powders, or filled into hard capsules to produce hard capsules.

이상에서 상술한 바와 같이 본 눈꽃동충하초, 번데기 동충하초, 시넨시스동충하초 및 상황버섯 생변환 인삼으로부터 선택된 1종이상의 열수 추출물 또는 용매 추출물은 인삼 진세노사이드와 베타글루칸의 생성, 항산화 효과, 항종양효과, 항피로효과 및 미백효과를 증대시키는 효과를 가진다. 따라서 본 발명에 따르면 상기추출물을 음료, 생약제제 등에 함유시킴에 의해 기존의 인삼 가공물에 비해 증가된 효능의 고 기능성 가공품을 제조할 수 있다.As described above, the at least one hydrothermal extract or solvent extract selected from Snow Cordyceps Sinensis, Chrysalis Cordyceps Sinensis, Sinensis Cordyceps Sinensis, and Situary Mushroom Biotransformation Ginseng may be used to produce ginseng ginsenosides and beta glucans, antioxidant effects, antitumor effects, It has the effect of increasing the antifatigue effect and the whitening effect. Therefore, according to the present invention, by containing the extract in beverages, herbal preparations, etc., it is possible to manufacture a highly functional processed product of increased efficacy compared to conventional ginseng processed products.

Claims (6)

인삼을 기본배지로 하여 미생물의 배지성분을 침지시키고 멸균하여 눈꽃동충하초, 번데기동충하초, 시넨시스동충하초 및 상황버섯 등 식용 및 약용버섯의 종균을 접종 및 배양 후 만들어지는 기능성 생변환 인삼의 제조법Method of manufacturing functional bio-converted ginseng produced after inoculation and incubation of spawns of edible and medicinal mushrooms such as Snow Cordyceps, Pupa Cordyceps, Sinensis Cordyceps and Situary Mushroom 제1항의 생변환인삼의 제조에 있어, 건삼원료를 소정의 크기로 절각하는 단계 및 미생물의 배지성분인 0.1-10% 효모추출물 및 쏘이톤을 건삼원료에 침지시켜 배지성분이 건삼원료에 스며들게 한 다음, 121도, 1.5 기압에서 15-60분간 멸균하는 것을 특징으로 하는 배양방법In the preparation of the raw ginseng of claim 1, the step of cutting the dry ginseng raw material to a predetermined size and 0.1-10% yeast extract and Soyton, which is a medium component of the microorganism, is immersed in the dry ginseng raw material to infiltrate the dry ginseng raw Next, the culture method, characterized in that sterilization for 15-60 minutes at 121 degrees, 1.5 atm 제1항에 있어서, 접종후 15-35도의 배양 온도에서 1-4주간 배양하여 균사의 생육을 관찰 한 후 다시 하온(적정온도에서 5도 이하) 및 100-1,000 lux의 빛을 가하여 생리활성물질의 생성유도를 특징으로 하는 배양방법The bioactive substance according to claim 1, incubated for 1-4 weeks at the incubation temperature of 15-35 degrees after the inoculation, and the growth of hyphae is observed, followed by addition of low temperature (less than 5 degrees at the appropriate temperature) and light of 100-1,000 lux. Culture method characterized by the induction of 제1항의 생변환 추출물을 유효성분으로 함유하는 것을 특징으로는 기능성 음료 및 주류Functional drink and liquor comprising the bioconversion extract of claim 1 as an active ingredient 제1항의 생변환 추출물을 유효성분으로 함유하고, 여기에 약제학적으로 허용되는 부형제 및 보조제를 혼합하여 약제학적으로 허용되는 방법으로 제형화한 약학적 제제A pharmaceutical formulation containing the bioconversion extract of claim 1 as an active ingredient and formulated in a pharmaceutically acceptable manner by mixing a pharmaceutically acceptable excipient and adjuvant therein. 제5항에서 상기 제형이 과립제 또는 캅셀제인 제제The formulation according to claim 5, wherein the formulation is a granule or a capsule.
KR1020030039079A 2003-06-17 2003-06-17 Making methods of effectively bio-transformed ginsengs using the cultivation of edible and medicinal mushrooms KR20040108476A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020030039079A KR20040108476A (en) 2003-06-17 2003-06-17 Making methods of effectively bio-transformed ginsengs using the cultivation of edible and medicinal mushrooms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020030039079A KR20040108476A (en) 2003-06-17 2003-06-17 Making methods of effectively bio-transformed ginsengs using the cultivation of edible and medicinal mushrooms

Publications (1)

Publication Number Publication Date
KR20040108476A true KR20040108476A (en) 2004-12-24

Family

ID=37382399

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020030039079A KR20040108476A (en) 2003-06-17 2003-06-17 Making methods of effectively bio-transformed ginsengs using the cultivation of edible and medicinal mushrooms

Country Status (1)

Country Link
KR (1) KR20040108476A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101111404B1 (en) * 2007-12-31 2012-02-24 동국대학교 경주캠퍼스 산학협력단 The extract of Fomitopsis pinicola and food supplement comprising the same for prevention and treatment of insulin resistance and obesity
CN106134758A (en) * 2015-04-10 2016-11-23 北京银桥绿色农业科技有限公司 Aseptic silkworm inoculation Cordyceps militaris (L.) Link. fungus cultivates silkworm grass method
CN111494255A (en) * 2020-06-03 2020-08-07 广东芭薇生物科技股份有限公司 Composition containing ginseng cordyceps sinensis fermentation extract and application of composition in cosmetics

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101111404B1 (en) * 2007-12-31 2012-02-24 동국대학교 경주캠퍼스 산학협력단 The extract of Fomitopsis pinicola and food supplement comprising the same for prevention and treatment of insulin resistance and obesity
CN106134758A (en) * 2015-04-10 2016-11-23 北京银桥绿色农业科技有限公司 Aseptic silkworm inoculation Cordyceps militaris (L.) Link. fungus cultivates silkworm grass method
CN111494255A (en) * 2020-06-03 2020-08-07 广东芭薇生物科技股份有限公司 Composition containing ginseng cordyceps sinensis fermentation extract and application of composition in cosmetics

Similar Documents

Publication Publication Date Title
KR100922311B1 (en) Methods of culturing Inonotus obliquus, Phellinus linteus, Ganoderma lucidum, Sparassis crispa and Vegetable Worms for production of substances containing AHCC
Zhou et al. Applied modern biotechnology for cultivation of Ganoderma and development of their products
KR101269410B1 (en) Methods of culturing Inonotus obliquus, Phellinus linteus, Ganoderma lucidum, Sparassis crispa and Vegetable Worms using mushroom media
KR101370386B1 (en) Preparation method of fermented red ginseng using effective micro-organisms
KR101467903B1 (en) The preparing method of immune improving agents
KR101681810B1 (en) Ginseng preparations containing abundant ginsenoside using a beauveria bassiana and method thereof
KR20100114673A (en) The manufacturing method of fermented aloe for whitening effect in skin, and the functional whitening cosmetics containing fermented aloe
KR101851195B1 (en) Fermented mulberry leaves, femented mulberry leaves extract and use there of
Choi et al. Enhancement of anti-complementary and radical scavenging activities in the submerged culture of Cordyceps sinensis by addition of citrus peel
KR20100021110A (en) Medium composition for phellinus linteus culture
KR101664380B1 (en) Method for Making Fermented Food Containing Red Ginseng by Using Mixed Aspergillus Oryzae and Lactic Acid Bacteria
CN101711774A (en) Application of Phellinus pini polysaccharide extract in preparing medicament for preventing and treating tumor metastasis
US20040106187A1 (en) Composition for the culturing of Phellinus linteus mycelium
KR20040108476A (en) Making methods of effectively bio-transformed ginsengs using the cultivation of edible and medicinal mushrooms
JP4109572B2 (en) Cordyceps mycelium culture method and composition
KR100706132B1 (en) Composition for the culturing of Phellinus linteus mycelium
KR20190030850A (en) Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof
KR20220020147A (en) Method for preparing Phellinus linteus mycelia extract or Phellinus linteus mycelia extract powder and composition for enhancing immunity comprising them as an active ingredient
KR101219683B1 (en) Composition with tyrosinase inhibition activity of grain Koji fermented with Aspergillus oryzae and Astragali Radix and method thereof
KR20000060083A (en) Fermented product using lactic acid bacteria and cosmetic composition
KR20210101707A (en) Composition comprising a fermented lactobacillus salivarius for preventing or improving of atopic dermatitis
KR20050004992A (en) Methods of the mycelial culture products of mushrooms using desalted deep seawater for increasing the extracellular glycoprotein
KR101755338B1 (en) Process for preparation of grifola frondosa fruit body with twice fermentation and functional grifola frondosa fruit body fermentative products
KR20110122389A (en) Fermented plant germ extract which inhibits the growth of cancer cells and method for preparing the same
KR102357617B1 (en) Composition comprising extracts of mushroom mixed mycelia, Aconogonon alpinum, Orostachys japonicus and Amaranthus mangostanus for prevention or treating gout

Legal Events

Date Code Title Description
WITN Withdrawal due to no request for examination